ELCC 2024

ELCC 2024
March 20-23, 2024
Prague, Czech Republic

European Lung Cancer Congress 2024 .

Explore more information for Gilead Oncology therapies
Results (1)

Sacituzumab govitecan (SG) + pembrolizumab (pembro) in first-line (1L) metastatic non-small cell lung cancer (mNSCLC): efficacy results by histology from the EVOKE-02 study